Goyos Ana, Guselnikov Sergey, Chida Asiya S, Sniderhan Lynn F, Maggirwar Sanjay B, Nedelkovska Hristina, Robert Jacques
Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY 14642, USA.
Eur J Immunol. 2007 Jun;37(6):1494-501. doi: 10.1002/eji.200636570.
Nonclassical MHC class Ib (class Ib) genes are found in all jawed vertebrates, and their products are hypothesized to be indicators of intracellular stress and malignancy. They may be involved in immune recognition of classical MHC class Ia (class Ia)-low or -negative tumor cells through their interaction with T cell receptors and/or non-T cell inhibitory or triggering receptors expressed by NK cells and T cells. In the frog Xenopus, the molecular chaperone gp96 mediates a potent immune response involving antigen-specific classical class Ia-unrestricted CD8+ CTL (CCU-CTL) against a transplantable thymic tumor (15/0) that does not express class Ia molecules. We hypothesized that Xenopus nonclassical class Ib gene products (XNC) are involved in gp96-mediated CCU-CTL anti-tumor responses. To investigate the involvement of class Ib gene products in Xenopus anti-tumor responses, we generated, for the first time in ectothermic vertebrates, stable tumor transfectants expressing short hairpin RNA (shRNA) to silence either XNC directly or beta2m to prevent class Ib surface expression. Both types of 15/0 transfectants are more resistant to CCU-CTL killing, more tumorigenic and more susceptible to NK-like cell killing. This study provides in vitro and in vivo evidence of the evolutionary conservation of class Ib involvement in anti-tumor CD8+ T cell responses.
非经典MHC Ib类(Ib类)基因存在于所有有颌脊椎动物中,其产物被认为是细胞内应激和恶性肿瘤的指标。它们可能通过与T细胞受体和/或由NK细胞和T细胞表达的非T细胞抑制或触发受体相互作用,参与对经典MHC Ia类(Ia类)低表达或阴性肿瘤细胞的免疫识别。在非洲爪蟾中,分子伴侣gp96介导了一种强大的免疫反应,涉及针对不表达Ia类分子的可移植胸腺肿瘤(15/0)的抗原特异性经典Ia类非限制性CD8 + CTL(CCU-CTL)。我们假设非洲爪蟾非经典Ib类基因产物(XNC)参与gp96介导的CCU-CTL抗肿瘤反应。为了研究Ib类基因产物在非洲爪蟾抗肿瘤反应中的作用,我们首次在变温脊椎动物中产生了稳定的肿瘤转染细胞,这些细胞表达短发夹RNA(shRNA)以直接沉默XNC或沉默β2m以阻止Ib类分子在表面表达。两种类型的15/0转染细胞对CCU-CTL杀伤更具抗性,更具致瘤性,并且对NK样细胞杀伤更敏感。这项研究提供了体外和体内证据,证明Ib类参与抗肿瘤CD8 + T细胞反应具有进化保守性。